Despite fasting overnight, gastric POCUS (Figure 1) performed on the morning of surgery revealed solid gastric contents (full stomach)
For patients experiencing significant symptoms, temporarily pausing therapy, maintaining the current dose for an additional 2-4 weeks before advancing, or implementing smaller dose increments when formulation allows, may improve tolerance
North America holds 45% market share (2024), driven by advanced healthcare systems, high diabetes prevalence, and strong pharmaceutical innovation investments
Potential Side Effects and Digestive Changes The most common adverse effects of Wegovy involve the gastrointestinal system, with nausea, diarrhoea, vomiting, constipation, and abdominal pain reported in clinical trials, as detailed in the MHRA-approved SmPC